Increased vaccine tolerability and protection via NF-κB modulation
Open Access
- 11 September 2020
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (37) , eaaz8700
Abstract
Inflammation can be decoupled from the antigen-presenting actions of adjuvants using an immune potentiator that modulates NF-κB.Keywords
Funding Information
- National Science Foundation (DGE-1321846)
- National Institutes of Health (1U01Al124286-01)
- National Institutes of Health (1DP2Al112194-01)
- National Institutes of Health (GM099594)
- Defense Threat Reduction Agency (HDTRA11810052)
This publication has 83 references indexed in Scilit:
- Viral-induced encephalitis initiates distinct and functional CD103 + CD11b + brain dendritic cell populations within the olfactory bulbProceedings of the National Academy of Sciences, 2012
- The Cord Blood Apgar: a novel scoring system to optimize selection of banked cord blood grafts for transplantation (CME)Transfusion, 2011
- Vaccine Adjuvants: Putting Innate Immunity to WorkImmunity, 2010
- Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1Science, 2010
- Toll-Like Receptor AgonistsThe Cancer Journal, 2010
- The Nuclear Factor NF- B Pathway in InflammationCold Spring Harbor Perspectives in Biology, 2009
- The NF- B Family of Transcription Factors and Its RegulationCold Spring Harbor Perspectives in Biology, 2009
- Inhibitors of NF-κB signaling: 785 and countingOncogene, 2006
- Toll-like receptor signallingNature Reviews Immunology, 2004
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999